{
  "name": "Vertex Pharmaceuticals",
  "slug": "vertex-pharmaceuticals",
  "ticker": "VRTX",
  "fetched_at": "2025-08-18T12:24:31.992140+00:00",
  "news": [
    {
      "title": "Vertex Pharmaceuticals: Promising Growth with Successful Launch and Strong Pipeline - TipRanks",
      "link": "https://news.google.com/rss/articles/CBMixwFBVV95cUxQWEN0dzJBekJiaFJYMm9qbVN5Q3djdThMV0VTSlI2aDRDSDM2ZHhCOHI5N3BxTzRMcnVRVzNBM05Sc21acGdKcXRhM01XTkdNT1QyLVRpWmFiMkJKb1lOZkxzMlBnbHFWbzAzUXdPNTBncG9ReGlkLXBMaFNIc1NRSTV1UjRxcUFmQ0RiTl9RUjJFdU9jQ0V0Si0wdW9mQ01ITWo1WVhzbUhEV253dmh4LVI0TnJvZ3BCVWNfNFFDVXowc0xvdU8w?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMixwFBVV95cUxQWEN0dzJBekJiaFJYMm9qbVN5Q3djdThMV0VTSlI2aDRDSDM2ZHhCOHI5N3BxTzRMcnVRVzNBM05Sc21acGdKcXRhM01XTkdNT1QyLVRpWmFiMkJKb1lOZkxzMlBnbHFWbzAzUXdPNTBncG9ReGlkLXBMaFNIc1NRSTV1UjRxcUFmQ0RiTl9RUjJFdU9jQ0V0Si0wdW9mQ01ITWo1WVhzbUhEV253dmh4LVI0TnJvZ3BCVWNfNFFDVXowc0xvdU8w?oc=5\" target=\"_blank\">Vertex Pharmaceuticals: Promising Growth with Successful Launch and Strong Pipeline</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">TipRanks</font>",
      "published": "2025-08-18T11:55:03+00:00",
      "source": "TipRanks"
    },
    {
      "title": "Vertex Pharma CEO Buys the Stock Dip - Barron's",
      "link": "https://news.google.com/rss/articles/CBMic0FVX3lxTE1FQVJjT2c1VUFSWUwwV0FtZGx1cW9kaVJ3SWctVUxmVjQ5Mm5IUzI4UzY1ZkdLbnJTRWNLTTFZN09Nc3FVanM0RkRIZVNLMkZ6Uk1JS0pxVk1BNFVHT0VYY08tbThSeGJmNTVFYnBhZ0MzcFk?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMic0FVX3lxTE1FQVJjT2c1VUFSWUwwV0FtZGx1cW9kaVJ3SWctVUxmVjQ5Mm5IUzI4UzY1ZkdLbnJTRWNLTTFZN09Nc3FVanM0RkRIZVNLMkZ6Uk1JS0pxVk1BNFVHT0VYY08tbThSeGJmNTVFYnBhZ0MzcFk?oc=5\" target=\"_blank\">Vertex Pharma CEO Buys the Stock Dip</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Barron's</font>",
      "published": "2025-08-15T21:52:00+00:00",
      "source": "Barron's"
    },
    {
      "title": "Vertex Pharmaceuticals (VRTX) Declines More Than Market: Some Information for Investors - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMikAFBVV95cUxOWmhjb0p3UkJ0MWd4M0lkejAtUG8xdkY5WFpJMTc4MEtGVjJIWE5vOUVjQmE3ZlVQbWx3ZFJWbFl1amZHQ3JnbnRCbDNya2FkZFlyQ1hOM2F0ZHFQWEx5eXVsNW9RU0dxT2FCWHlfRURWUnNINVI3N3Y2aEdxMXNJNUpLVmtrTUxubzFER0owVTg?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMikAFBVV95cUxOWmhjb0p3UkJ0MWd4M0lkejAtUG8xdkY5WFpJMTc4MEtGVjJIWE5vOUVjQmE3ZlVQbWx3ZFJWbFl1amZHQ3JnbnRCbDNya2FkZFlyQ1hOM2F0ZHFQWEx5eXVsNW9RU0dxT2FCWHlfRURWUnNINVI3N3Y2aEdxMXNJNUpLVmtrTUxubzFER0owVTg?oc=5\" target=\"_blank\">Vertex Pharmaceuticals (VRTX) Declines More Than Market: Some Information for Investors</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-07-15T07:00:00+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "The 3 Things That Matter for Vertex Pharmaceuticals Now - The Motley Fool",
      "link": "https://news.google.com/rss/articles/CBMimAFBVV95cUxNWl9vejVmVmZ1bzVtRlBYYUI4X3lwTXhidXU4ZUExQWV0YXRtdXlsaFduSy1xb0dRc1otM0JUUjlTTmhmVERDWnBsVnhVVG53QnRzc3JmZGdQV0RnS1g0cS1lN3ZMRjFncFB1VGZ4bVpWMEw0d3B0bTNQeEVDMjFiVTFyMDY2Q3VDQ3JhVXI3N0FQTnFPLW4xag?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMimAFBVV95cUxNWl9vejVmVmZ1bzVtRlBYYUI4X3lwTXhidXU4ZUExQWV0YXRtdXlsaFduSy1xb0dRc1otM0JUUjlTTmhmVERDWnBsVnhVVG53QnRzc3JmZGdQV0RnS1g0cS1lN3ZMRjFncFB1VGZ4bVpWMEw0d3B0bTNQeEVDMjFiVTFyMDY2Q3VDQ3JhVXI3N0FQTnFPLW4xag?oc=5\" target=\"_blank\">The 3 Things That Matter for Vertex Pharmaceuticals Now</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">The Motley Fool</font>",
      "published": "2025-07-28T07:00:00+00:00",
      "source": "The Motley Fool"
    },
    {
      "title": "Vertex Pharmaceuticals: The Stock Hasn't Dropped Enough Yet (NASDAQ:VRTX) - Seeking Alpha",
      "link": "https://news.google.com/rss/articles/CBMimgFBVV95cUxNeHYzalNfR1E1cWFrb0Y1SFYxMXQyNnJwV05BcGh3OWk2d21XYzBSYTAtbHZfT25tdFJZRU1uR1lsNXpoeGNENS1mMDZrdmVLRmVZMUZSWmZBOUM0dC1CUU9yOW1vV0J2VWdqbVN4eHotLW90NlF0U3E5TjFIaGVUYVkxakltamVrZjJPQlZ1Nk1PX2gyZUdCOEl3?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMimgFBVV95cUxNeHYzalNfR1E1cWFrb0Y1SFYxMXQyNnJwV05BcGh3OWk2d21XYzBSYTAtbHZfT25tdFJZRU1uR1lsNXpoeGNENS1mMDZrdmVLRmVZMUZSWmZBOUM0dC1CUU9yOW1vV0J2VWdqbVN4eHotLW90NlF0U3E5TjFIaGVUYVkxakltamVrZjJPQlZ1Nk1PX2gyZUdCOEl3?oc=5\" target=\"_blank\">Vertex Pharmaceuticals: The Stock Hasn't Dropped Enough Yet (NASDAQ:VRTX)</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Seeking Alpha</font>",
      "published": "2025-08-12T18:34:19+00:00",
      "source": "Seeking Alpha"
    },
    {
      "title": "Stock Analysis | Vertex Pharmaceuticals Outlook - Technicals Favor Growth Despite Mixed Analyst Sentiment - AInvest",
      "link": "https://news.google.com/rss/articles/CBMixwFBVV95cUxNX3BnX21rekFCQUxfYm9tM3VkV3FNTFVQTHpFRm81Tk5zdUhsQTZMTXFBb1k1RG1XXzNjaGE2SXJLVDhkWTFaT0pndEx1eTJrZlVaZDdOUjZoMVFuRnY4WlNEeVNCNGlZQ2ttdnFRdGZCNVF6blY2d0hXUzJ3OGQxdU12eG8tejVvN2t0YWNCRC1MejdsMkpKejdiQjVGdUM1N2JyemVxRFR5WGYtQkxCaHlMRm5EVk5lcUZULWFEM0VrVnF2bTU0?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMixwFBVV95cUxNX3BnX21rekFCQUxfYm9tM3VkV3FNTFVQTHpFRm81Tk5zdUhsQTZMTXFBb1k1RG1XXzNjaGE2SXJLVDhkWTFaT0pndEx1eTJrZlVaZDdOUjZoMVFuRnY4WlNEeVNCNGlZQ2ttdnFRdGZCNVF6blY2d0hXUzJ3OGQxdU12eG8tejVvN2t0YWNCRC1MejdsMkpKejdiQjVGdUM1N2JyemVxRFR5WGYtQkxCaHlMRm5EVk5lcUZULWFEM0VrVnF2bTU0?oc=5\" target=\"_blank\">Stock Analysis | Vertex Pharmaceuticals Outlook - Technicals Favor Growth Despite Mixed Analyst Sentiment</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">AInvest</font>",
      "published": "2025-08-15T03:21:13+00:00",
      "source": "AInvest"
    },
    {
      "title": "Vertex's trial failure, scrapped study cloud pain drug push; shares slump - Reuters",
      "link": "https://news.google.com/rss/articles/CBMi2gFBVV95cUxQOEk3LXI4VjBsT0J1aDNCc3BvU3ZZYTgzRlBGOEFuejM3QzFST3lZT3hMUGtNVFFDazVoblY1bUM3bHo2Q1BpOXdCMGx2b0ZvS19qNFl1M3AzUG9zQ1haaWU2Wnk4Y1ZzaEVRRC14RExYMWh3MGM2OWRFekF6NW1yNjhzeXNySFVqc1hhdEdlMjI3ZG4tcnVIdWNGeVI3eU9PSzA5eVdvQVBRNVJETFI5SGtRZDhPWkhxVFllcmp3U3NsZVRfRDRxdGNLbExUS29JcDhkMlV0YTBSQQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi2gFBVV95cUxQOEk3LXI4VjBsT0J1aDNCc3BvU3ZZYTgzRlBGOEFuejM3QzFST3lZT3hMUGtNVFFDazVoblY1bUM3bHo2Q1BpOXdCMGx2b0ZvS19qNFl1M3AzUG9zQ1haaWU2Wnk4Y1ZzaEVRRC14RExYMWh3MGM2OWRFekF6NW1yNjhzeXNySFVqc1hhdEdlMjI3ZG4tcnVIdWNGeVI3eU9PSzA5eVdvQVBRNVJETFI5SGtRZDhPWkhxVFllcmp3U3NsZVRfRDRxdGNLbExUS29JcDhkMlV0YTBSQQ?oc=5\" target=\"_blank\">Vertex's trial failure, scrapped study cloud pain drug push; shares slump</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Reuters</font>",
      "published": "2025-08-04T07:00:00+00:00",
      "source": "Reuters"
    },
    {
      "title": "Why Vertex Pharma Is Feeling The Pain Despite A Second-Quarter Beat - Investor's Business Daily",
      "link": "https://news.google.com/rss/articles/CBMimwFBVV95cUxPMGFNTjBhUnB5R2tQVzJIZWN2aHlJZ09Rd0VWaThnSWlOd2NKODBHWXo1ZjVVY1o2bzk0aUQtTG5MN0hMNmo4akdyT0tZZ1IwN2ZsQkZSSnJ5cWtMTmRWNGNOSVEydjc4QnZWTmdxR3ZCblhTQ0VEUXFZazdTMndnWmhuU0s2YmdEVHVxNXRFNFRnMi1ROW83MUF3bw?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMimwFBVV95cUxPMGFNTjBhUnB5R2tQVzJIZWN2aHlJZ09Rd0VWaThnSWlOd2NKODBHWXo1ZjVVY1o2bzk0aUQtTG5MN0hMNmo4akdyT0tZZ1IwN2ZsQkZSSnJ5cWtMTmRWNGNOSVEydjc4QnZWTmdxR3ZCblhTQ0VEUXFZazdTMndnWmhuU0s2YmdEVHVxNXRFNFRnMi1ROW83MUF3bw?oc=5\" target=\"_blank\">Why Vertex Pharma Is Feeling The Pain Despite A Second-Quarter Beat</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Investor's Business Daily</font>",
      "published": "2025-08-05T07:00:00+00:00",
      "source": "Investor's Business Daily"
    }
  ],
  "product_launches": [
    {
      "title": "Vertex Pharmaceuticals: Promising Growth with Successful Launch and Strong Pipeline - TipRanks",
      "link": "https://news.google.com/rss/articles/CBMixwFBVV95cUxQWEN0dzJBekJiaFJYMm9qbVN5Q3djdThMV0VTSlI2aDRDSDM2ZHhCOHI5N3BxTzRMcnVRVzNBM05Sc21acGdKcXRhM01XTkdNT1QyLVRpWmFiMkJKb1lOZkxzMlBnbHFWbzAzUXdPNTBncG9ReGlkLXBMaFNIc1NRSTV1UjRxcUFmQ0RiTl9RUjJFdU9jQ0V0Si0wdW9mQ01ITWo1WVhzbUhEV253dmh4LVI0TnJvZ3BCVWNfNFFDVXowc0xvdU8w?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMixwFBVV95cUxQWEN0dzJBekJiaFJYMm9qbVN5Q3djdThMV0VTSlI2aDRDSDM2ZHhCOHI5N3BxTzRMcnVRVzNBM05Sc21acGdKcXRhM01XTkdNT1QyLVRpWmFiMkJKb1lOZkxzMlBnbHFWbzAzUXdPNTBncG9ReGlkLXBMaFNIc1NRSTV1UjRxcUFmQ0RiTl9RUjJFdU9jQ0V0Si0wdW9mQ01ITWo1WVhzbUhEV253dmh4LVI0TnJvZ3BCVWNfNFFDVXowc0xvdU8w?oc=5\" target=\"_blank\">Vertex Pharmaceuticals: Promising Growth with Successful Launch and Strong Pipeline</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">TipRanks</font>",
      "published": "2025-08-18T11:55:03+00:00",
      "source": "TipRanks"
    },
    {
      "title": "Vertex tops estimates on cystic fibrosis treatment strength, new products - Reuters",
      "link": "https://news.google.com/rss/articles/CBMi2AFBVV95cUxQV1RfcWFhZlB4RnlGTUNfYlJTOEFKaHREZHlEeV9GVHpnaW1zRDliVlMtX3dWdjZkS2RNRWhZaXc0NmdVcW10bVhmQV9NNlh3b3IwckhEME9rTFlIci1hRDF4RlFzRWprOWFTdjlVV1d4dVpIaVFGWXBiWF9tbnJmcFEydUxiNDF1TVJfLTI4QmtvcnIwWVhYd3hNTno2aFhpZF9WNFZjX3lJLVVsNjZfcWZOVTVzU2lXYzV1cmw0bDRpTUFiWjJLUElvRk15d1RKLWJnQy10MmU?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi2AFBVV95cUxQV1RfcWFhZlB4RnlGTUNfYlJTOEFKaHREZHlEeV9GVHpnaW1zRDliVlMtX3dWdjZkS2RNRWhZaXc0NmdVcW10bVhmQV9NNlh3b3IwckhEME9rTFlIci1hRDF4RlFzRWprOWFTdjlVV1d4dVpIaVFGWXBiWF9tbnJmcFEydUxiNDF1TVJfLTI4QmtvcnIwWVhYd3hNTno2aFhpZF9WNFZjX3lJLVVsNjZfcWZOVTVzU2lXYzV1cmw0bDRpTUFiWjJLUElvRk15d1RKLWJnQy10MmU?oc=5\" target=\"_blank\">Vertex tops estimates on cystic fibrosis treatment strength, new products</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Reuters</font>",
      "published": "2025-08-04T07:00:00+00:00",
      "source": "Reuters"
    },
    {
      "title": "(suzetrigine), a First-in-Class Treatment for Adults With Moderate-to-Severe Acute Pain - Vertex Pharmaceuticals Newsroom",
      "link": "https://news.google.com/rss/articles/CBMivgFBVV95cUxQNGhZSnljSUNJSGJ4SzNPVXdNeXNncWRyT1dUWVY2VDVxWDFhamJGQUtSWlhJLVVJMmhSQjROckJNemJGZVlkY3ZmR0ZmYXBiX1J1ZHExdk1ZOW1wTWp5T1ZWa283c2RkYjdkUlgwMEtNejlNb3NJbVZJZlpyVmNweWptQ3dWeDAtV0NfVEJXNG5RU1pTZFRUY01hOEd0SXdwMXFTdEpGTnJTMklMX2NRUnBwUGhndjcyWUJzc0pn?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMivgFBVV95cUxQNGhZSnljSUNJSGJ4SzNPVXdNeXNncWRyT1dUWVY2VDVxWDFhamJGQUtSWlhJLVVJMmhSQjROckJNemJGZVlkY3ZmR0ZmYXBiX1J1ZHExdk1ZOW1wTWp5T1ZWa283c2RkYjdkUlgwMEtNejlNb3NJbVZJZlpyVmNweWptQ3dWeDAtV0NfVEJXNG5RU1pTZFRUY01hOEd0SXdwMXFTdEpGTnJTMklMX2NRUnBwUGhndjcyWUJzc0pn?oc=5\" target=\"_blank\">(suzetrigine), a First-in-Class Treatment for Adults With Moderate-to-Severe Acute Pain</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Vertex Pharmaceuticals Newsroom</font>",
      "published": "2025-01-30T08:00:00+00:00",
      "source": "Vertex Pharmaceuticals Newsroom"
    },
    {
      "title": "Vertex Reports Second Quarter 2025 Financial Results - Business Wire",
      "link": "https://news.google.com/rss/articles/CBMirgFBVV95cUxQMWJFb2Noa0FVRVkzbmRWczF1SW5EcTk5RDNFUUxILUdsYW9veGlEbnV1SkY2S0p2WFRBYV9JVFFEUkUtc3BFN1hhRk55TklJcFlOWnlIU012RlhqVnl3aU5oUHpOZ3B6TXNReExoMEl5QWRRRHBVOE9aUUJudVZzLV9qTUhOQ1hZTHlnNTNuN2ZPb2tCV056enlVR1dWVl9Lb2dldEFxcG92UklZeEE?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMirgFBVV95cUxQMWJFb2Noa0FVRVkzbmRWczF1SW5EcTk5RDNFUUxILUdsYW9veGlEbnV1SkY2S0p2WFRBYV9JVFFEUkUtc3BFN1hhRk55TklJcFlOWnlIU012RlhqVnl3aU5oUHpOZ3B6TXNReExoMEl5QWRRRHBVOE9aUUJudVZzLV9qTUhOQ1hZTHlnNTNuN2ZPb2tCV056enlVR1dWVl9Lb2dldEFxcG92UklZeEE?oc=5\" target=\"_blank\">Vertex Reports Second Quarter 2025 Financial Results</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Business Wire</font>",
      "published": "2025-08-04T07:00:00+00:00",
      "source": "Business Wire"
    },
    {
      "title": "Vertex Pharmaceuticals: A Masterclass in Diversified Innovation and Financial Discipline - AInvest",
      "link": "https://news.google.com/rss/articles/CBMiswFBVV95cUxOZHpaSFhxbWZ5TkFaSlY2eDUwTW9fd2QwelRqS2tYQy1kclVuVmpjNHp2MmZCOGJ6UkZ2OVFicXlYcEhDSU9RZm9GWGJYWC0tTlFsc3NBdjFvaVA0V1lTX3h5Y29McmpaUGY1bDJma004M3FBTGc5OXh4b1p5MGNHWEhlUU1nNWI4ei1HTjBsRjBVbnJsZGtXdU5fNlpJS0QzaHc5VFZOSzZsbTF6SWxxRGZkaw?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiswFBVV95cUxOZHpaSFhxbWZ5TkFaSlY2eDUwTW9fd2QwelRqS2tYQy1kclVuVmpjNHp2MmZCOGJ6UkZ2OVFicXlYcEhDSU9RZm9GWGJYWC0tTlFsc3NBdjFvaVA0V1lTX3h5Y29McmpaUGY1bDJma004M3FBTGc5OXh4b1p5MGNHWEhlUU1nNWI4ei1HTjBsRjBVbnJsZGtXdU5fNlpJS0QzaHc5VFZOSzZsbTF6SWxxRGZkaw?oc=5\" target=\"_blank\">Vertex Pharmaceuticals: A Masterclass in Diversified Innovation and Financial Discipline</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">AInvest</font>",
      "published": "2025-08-04T07:00:00+00:00",
      "source": "AInvest"
    }
  ],
  "stock": {
    "ticker": "VRTX",
    "currency": "USD",
    "latest": {
      "date": "2025-08-15",
      "close": 392.7900085449219
    },
    "history": [
      {
        "date": "2025-08-07",
        "close": 375.6300048828125
      },
      {
        "date": "2025-08-08",
        "close": 366.5400085449219
      },
      {
        "date": "2025-08-11",
        "close": 374.4599914550781
      },
      {
        "date": "2025-08-12",
        "close": 387.7699890136719
      },
      {
        "date": "2025-08-13",
        "close": 395.9200134277344
      },
      {
        "date": "2025-08-14",
        "close": 390.29998779296875
      },
      {
        "date": "2025-08-15",
        "close": 392.7900085449219
      }
    ],
    "name": "Vertex Pharmaceuticals Incorpor"
  }
}